An interview discussing his break-throughs in molecular biology, thrombotic hazards of Cox II inhibitors and the relationships between molecular clocks and aging.
Dr. Jennifer Manly, one of Irving Institute's 2022 Senior Mentors of the Year, weighs in on the efficacy of new Alzheimer's drug, donanemab, that may be approved in the US this year.
TL1 Co-Director Dr. Jacquelyn Y. Taylor will serve as one of the Principal Investigators for this initiative to reduce maternal mortality and morbidity for all birthing people in the state.
Based on recommendations, CUIMC research leadership will start a staged implementation this year in collaboration with individual CUIMC schools, Columbia University, and NYP.
Dean Katrina Armstrong discusses the future of biobanking at CUIMC after a recent $8 million construction award from the National Institutes of Health.
The Irving Institute for Clinical and Translational Research is honored to announce four new Herbert and Florence Irving Scholars for the 2023-2026 cohort.
